Author: Michelle Prudhomme

Advances in Anticancer Agents in Medicinal Chemistry

Volume 2

eBook: US $39 Special Offer (PDF + Printed Copy): US $162
Printed Copy: US $143
Library License: US $156
ISSN: 2589-2819 (Print)
ISSN: 2214-4331 (Online)
ISBN: 978-1-60805-715-3 (Print)
ISBN: 978-1-60805-496-1 (Online)
Year of Publication: 2013
DOI: 10.2174/97816080549611130201


Advances in Anticancer Agents in Medicinal Chemistry is an exciting eBook series comprising a selection of updated articles previously published in the peer-reviewed journal Anti-Cancer Agents in Medicinal Chemistry. The second Volume of this eBook series gathers updated reviews on several classes of molecules exhibiting anticarcinogenic potential as well as some important targets for the development of novel anticancer drugs.

Featured Anti-cancer molecules:

  • - Marine macrolides and their biological targets
  • - Organometallic supramolecular complexes including gold-based anticancer agents, anti-cancer vaccines
  • - glyconanoparticles,
  • - isatin-based compounds,
  • - tripentone families of potential anticancer drugs

Drug targets in this volume include:

  • - selective estrogen receptor modulators,
  • - leukemia stem cells,
  • - glioblastoma cell migratory mechanisms
  • - Tyrosyl-DNA phosphodiesterase 1

Advances in Anticancer Agents in Medicinal Chemistry will be of particular interest to readers interested in anticancer drug therapy as the series provides relevant reviews written by experts in this important field.

Indexed in: Book Citation Index, Science Edition, EBSCO, Ulrich's Periodicals Directory.


- Pp. i
William A. Denny
Download Free


- Pp. ii-iii (2)
Michelle Prudhomme
Download Free

List of Contributors

- Pp. iv-viii (5)
Michelle Prudhomme
Download Free

Marine Macrolides: Blue Biotechnology Against Cancer

- Pp. 3-45 (43)
José G. Napolitano, Antonio H. Daranas, Manuel Norte, José J. Fernández
View Abstract

Recent Developments in Organometallic Supramolecular Complexes as Anticancer Drugs

- Pp. 46-129 (84)
Cheng-He Zhou, Hui-Zhen Zhang, Sheng-Feng Cui, Jing-Song Lv, Cong-Yan Yan, Kun Wan, Yi-Yi Zhang, Shao-Lin Zhang, Gui-Xin Cai, Rong-Xia Geng, Guri L.V. Damu
View Abstract

Perspective Gold(III)-Dithiocarbamato Anticancer Therapeutics: Learning from the Past, Moving to the Future

- Pp. 130-172 (43)
Luca Ronconi, Chiara Nardon, Giulia Boscutti, Dolores Fregona
View Abstract

Toward Anticancer Therapeutics Based on Glycidic Structures

- Pp. 173-253 (81)
Luca Gabrielli, Alice Capitoli, Laura Russo, David Bini, Francesca Taraballi, Cristina Lupo, Laura Cipolla
View Abstract

Recent Highlights in the Development of Isatin-Based Anticancer Agents

- Pp. 254-312 (59)
Kara L. Vine, Lidia Matesic, Julie M. Locke, Danielle Skropeta
View Abstract

Tripentones: A Promising Series of Potent Anti-Cancer Agents

- Pp. 313-343 (31)
Christophe Rochais, Sylvain Rault, Patrick Dallemagne
View Abstract

Selective Estrogen Receptor Modulators as Treatments and Preventives of Breast Cancer

- Pp. 344-396 (53)
Surojeet Sengupta, Jing Peng, Virgil C. Jordan
View Abstract

Targeting Leukemia Stem Cells with Novel Therapeutic Agents

- Pp. 397-409 (13)
Yaoyu Chen, Cong Peng, Dongguang Li, Shaoguang Li
View Abstract

Targeting Migrating Cells in Glioblastoma

- Pp. 410-443 (34)
Ranjith Babu, Chunhui Di, Austin K. Mattox, Steve Harward, Cory Adamson
View Abstract

Tyrosyl-DNA Phosphodiesterase 1 as a Target for Anticancer Therapy

- Pp. 444-471 (28)
Thomas S. Dexheimer, Shar-yin N. Huang, Smitha Antony, Christophe Marchand, Yves Pommier
View Abstract


- Pp. 472-484 (13)
Michelle Prudhomme
Download Free